ciencia-natureza
ANVISA Approves Polylaminin: Brazil's Breakthrough Treatment for Spinal Cord Injury
ANVISA granted landmark approval for polylaminin-based therapy for spinal cord injury in April 2026, offering the first disease-modifying treatment for paralysis patients in Brazil.
⏱️ 2 min📅 2026-04-21